Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Chemours (CC) Research & Development (2016 - 2025)

Chemours (CC) has 12 years of Research & Development data on record, last reported at $27.0 million in Q4 2025.

  • For Q4 2025, Research & Development rose 3.85% year-over-year to $27.0 million; the TTM value through Dec 2025 reached $108.0 million, down 0.92%, while the annual FY2025 figure was $108.0 million, 0.92% down from the prior year.
  • Research & Development reached $27.0 million in Q4 2025 per CC's latest filing, up from $26.0 million in the prior quarter.
  • Across five years, Research & Development topped out at $32.0 million in Q3 2022 and bottomed at $24.0 million in Q1 2021.
  • Average Research & Development over 5 years is $27.4 million, with a median of $27.0 million recorded in 2021.
  • Peak YoY movement for Research & Development: soared 35.0% in 2021, then decreased 13.33% in 2023.
  • A 5-year view of Research & Development shows it stood at $29.0 million in 2021, then increased by 3.45% to $30.0 million in 2022, then fell by 13.33% to $26.0 million in 2023, then changed by 0.0% to $26.0 million in 2024, then rose by 3.85% to $27.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $27.0 million in Q4 2025, $26.0 million in Q3 2025, and $28.0 million in Q2 2025.